ASCEND BY NTHRYS
Research Abroad Products

Interactomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Drug Target Interactome Validation and Selectivity Platform
Web-based platform screening lead compounds against comprehensive protein interaction networks to predict off-target effects and optimize drug selectivity before clinical trials. Delivers value through per-compound screening fees, subscription-based access for medicinal chemistry teams, and strategic partnerships with contract research organizations.
Protein Interaction Biomarker Discovery Services Click to view more details →
Circulating Biofluid Protein Complex Analysis Service
Specialized service capturing and characterizing disease-associated protein interaction complexes from blood, CSF, and other bodily fluids using immunoaffinity enrichment and mass spectrometry. Generates recurring revenue through sample processing contracts, biomarker discovery collaborations, and companion diagnostic development agreements.
Protein Interaction Biomarker Discovery Services Click to view more details →
Temporal Dynamics Protein Interaction Profiling Platform
Software platform integrating time-resolved interactomics data to identify dynamic protein interaction signatures that correlate with disease progression and treatment response. Monetizes through per-study analysis fees, ongoing biomarker monitoring subscriptions, and licensing to pharmaceutical companies developing disease-modifying therapeutics.
Protein Interaction Biomarker Discovery Services Click to view more details →
Multi-Omics Integration Platform for Interaction Biomarker Discovery
Integrated analytics platform combining proteomics, genomics, transcriptomics, and metabolomics data to identify protein interaction-based biomarkers with enhanced predictive power. Delivers revenue through cloud-based platform subscriptions, custom analysis packages, and data licensing agreements with personalized medicine companies.
Protein Interaction Biomarker Discovery Services Click to view more details →
Organ-on-Chip Protein Interaction Biomarker Validation System
Proprietary microfluidic device and service enabling validation of protein interaction biomarkers in physiologically relevant tissue microenvironments before clinical translation. Generates value through device sales, service contracts for biomarker validation studies, and licensing fees to pharmaceutical companies reducing preclinical development risk.
Protein Interaction Biomarker Discovery Services Click to view more details →
Real-Time Immunotherapy Response Interactome Monitoring Service
Clinical-grade service platform performing serial interactome profiling of immune cells during immunotherapy treatment to identify predictive interaction biomarkers of responders versus non-responders. Captures revenue through patient monitoring contracts, clinical trial support services, and data licensing partnerships with immuno-oncology companies.
Protein Interaction Biomarker Discovery Services Click to view more details →
Real-Time RNA-Protein Binding Kinetics SaaS Platform
A cloud-based analytics platform that measures and predicts RNA-protein binding kinetics in real-time using machine learning algorithms. Enterprises use this to accelerate drug discovery, reduce time-to-market for therapeutics, and command premium pricing for high-confidence binding predictions.
RNA-Protein Interactomics Analytics Platforms Click to view more details →
High-Throughput RNA Interactome Screening and Discovery Tool
A commercial genomics tool that identifies novel RNA-protein interactions at genome-wide scale using next-generation sequencing integration. Biotech companies license this to build proprietary interaction databases, de-risk R&D pipelines, and monetize findings through licensing agreements.
RNA-Protein Interactomics Analytics Platforms Click to view more details →
AI-Powered Structural RNA-Protein Complex Prediction Engine
An enterprise software solution leveraging deep learning to predict 3D structures of RNA-protein complexes from sequence data alone. This enables pharmaceutical clients to bypass expensive structural biology experiments, reducing R&D costs by 40-60% while accelerating lead optimization cycles.
RNA-Protein Interactomics Analytics Platforms Click to view more details →
Therapeutic Target Validation RNA-Protein Interactomics Platform
A specialized SaaS for validating disease-relevant RNA-protein interactions in clinical and research contexts using patient-derived samples. Pharmaceutical companies monetize this through subscription tiers, enabling them to derisk clinical trials and increase approval success rates for RNA-targeted therapeutics.
RNA-Protein Interactomics Analytics Platforms Click to view more details →
Quantitative RNA Binding Affinity Measurement Commercial Service
A managed service offering precise quantification of RNA-protein binding affinities through surface plasmon resonance and fluorescence-based assays. Biotech firms pay per-assay fees, enabling them to rapidly characterize hundreds of candidate interactions without maintaining in-house instrumentation.
RNA-Protein Interactomics Analytics Platforms Click to view more details →
MiRNA-Protein Target Interaction Database Licensing Platform
A proprietary, curated database and API providing experimentally validated miRNA-protein target interactions for commercial license. Subscription revenue scales as diagnostic, pharmaceutical, and synthetic biology companies integrate this data into their product pipelines and clinical decision-support systems.
RNA-Protein Interactomics Analytics Platforms Click to view more details →